Streetbeat News

Earnings

DCPH

Deciphera Pharmaceuticals (NASDAQ:DCPH) presented long-term results from the INTRIGUE Phase 3 study of QINLOCK in second-line GIST patients at the ASCO Gastrointestinal Cancers Symposium. The study compared QINLOCK to sunitinib, showing a median overall survival of 35.5 months for QINLOCK versus 31.5 months for sunitinib. QINLOCK demonstrated a favorable safety profile with fewer Grade 3/4 TEAEs and lower treatment discontinuation rates. The results support QINLOCK as a preferred second-line regimen for advanced GIST patients intolerant to sunitinib, as per NCCN Guidelines. An exploratory analysis showed clinical benefit for QINLOCK in patients with specific KIT mutations, leading to the INSIGHT Phase 3 study enrollment.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 4:14 pm

AMD

INTC

NVDA

TSM

Nvidia (NVDA) and AMD (AMD) stocks are trading higher after Taiwan Semiconductor Manufacturing Company (TSM) reported strong Q4 results, with revenue and EPS beating consensus estimates. TSMC's positive FY24 revenue growth forecast and capital budget also contributed to the optimism. Analysts highlighted Nvidia's value in the AI sector and both Nvidia and AMD's strong positioning due to their AI moat. Meetings at CES with Nvidia executives were optimistic, and the focus on AI and gaming technology at the event aligns with the companies' strategies. Nvidia plans to launch a China-specific chip by 2Q24, and India's Yotta intends to deploy Nvidia's H100s and H200s by 2025. Over the last 12 months, Nvidia's stock has surged over 228%, while AMD's has gained 134%. Wall Street analysts generally view AMD as a Buy, with Barclays' Tom O'Malley being the most optimistic.

Portfolio Pulse from Anusuya Lahiri

January 18, 2024 | 4:12 pm

SCHW

Charles Schwab Corp (NYSE:SCHW) reported Q4 earnings that exceeded expectations with an adjusted EPS of 68 cents, surpassing the consensus of 64 cents. Analysts from JMP Securities and Keefe, Bruyette & Woods provided their perspectives, with JMP reiterating a Market Outperform rating and a $77 price target, while Keefe downgraded the stock from Outperform to Market Perform and reduced the price target from $75 to $70. The company is undergoing a balance sheet repositioning in anticipation of a 'transition year' in 2024, with expectations of long-term positive outcomes including potential share repurchase program reinstatement by end of 2024 and significant net interest margin (NIM) expansion.

Portfolio Pulse from Surbhi Jain

January 18, 2024 | 4:07 pm

RAMP

LiveRamp (RAMP) shares are up following the announcement of its agreement to acquire Habu for approximately $200 million and reporting preliminary Q3 revenue results that exceeded expectations. Additionally, Benchmark has increased its price target for RAMP from $44 to $51.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 4:05 pm

MSFT

The article provides an analysis of Microsoft (NASDAQ:MSFT) in comparison to its competitors in the Software industry. It examines financial metrics such as P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Microsoft shows potential value with a lower P/E ratio than the industry average, a lower P/B ratio suggesting undervaluation, but a higher P/S ratio indicating possible overvaluation. The company's ROE is below the industry average, but it has a strong EBITDA and gross profit, indicating robust profitability. However, Microsoft's revenue growth is slightly lower than the industry average. The company also has a lower debt-to-equity ratio compared to its top 4 peers, suggesting a strong financial position.

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 4:00 pm

NVDA

NVIDIA (NASDAQ:NVDA) is analyzed in comparison to its competitors in the Semiconductors & Semiconductor Equipment industry. Key financial metrics show NVIDIA has a lower P/E ratio than the industry average, suggesting potential for growth. However, its high P/B and P/S ratios may indicate overvaluation. NVIDIA's ROE is significantly higher than the industry average, indicating efficient equity use. Despite lower EBITDA and gross profit compared to the industry, NVIDIA's revenue growth far exceeds the industry average. NVIDIA also has a lower debt-to-equity ratio compared to its top 4 peers, indicating a stronger financial position.

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 4:00 pm

WABC

Westamerica Bancorp (NASDAQ:WABC) reported Q4 earnings of $1.48 per share, surpassing the consensus estimate of $1.46, marking a 1.37% year-over-year increase. However, their quarterly sales of $80.73M fell slightly short of the $80.86M estimate, though they were up 1.40% from the previous year.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 3:58 pm

VFS

VinFast's stock price has declined following the company's announcement that it missed its delivery target for 2023. This news could negatively impact investor confidence and raise concerns about the company's ability to meet future targets.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 3:56 pm

UTEN

The U.S. Dollar Index (DXY) and U.S. Treasury yields rose due to strong economic data, reducing expectations for a Federal Reserve rate cut. Jobless claims dropped more than expected, and building permits exceeded estimates, while housing starts declined but still beat forecasts. The Philly Fed Manufacturing Index improved but remained in contraction. These indicators suggest a resilient economy, potentially affecting the Federal Reserve's interest rate decisions and providing opportunities in the homebuilder sector.

Portfolio Pulse from Piero Cingari

January 18, 2024 | 3:45 pm

QCOM

Qualcomm Inc (NASDAQ:QCOM) stock rose by 2.9% influenced by positive sentiment from Taiwan Semiconductor Mfg. Co. Ltd.'s (TSMC) strong Q4 financial results. TSMC's revenue and EPS exceeded consensus estimates, suggesting a healthy semiconductor industry, which may reflect well on companies like Qualcomm.

Portfolio Pulse from Henry Khederian

January 18, 2024 | 3:31 pm